-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Curis, Maintains $17 Price Target

Benzinga·03/20/2026 10:27:38
Listen to the news
HC Wainwright & Co. analyst Sara Nik reiterates Curis (NASDAQ:CRIS) with a Buy and maintains $17 price target.